Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
0.05% cyclosporine eye drops plus artificial tears for dry eye after herpes simplex virus keratitis
ChiCTR2200055914Phase 4Not yet recruiting
- Sponsor
- Department of Ophthalmology, the First Affiliated Hospital of Northwest University
- Start
- Jan 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of cyclosporine in dry eye syndrome (DED) and herpetic keratitis (2 arms), sponsored by Department of Ophthalmology, the First Affiliated Hospital of Northwest University. Primary endpoints: tear break-up time (TBUT), Schirmer test and 3 more. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)herpetic keratitis
Beyond the preview
Go deeper on ChiCTR2200055914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055914.